JPMorgan to Pilot Issuance of Deposit Tokens on the Base Network

On June 18th. According to reports from Politico, the U.S. Senate passed the significant cryptocurrency legislation, the GENIUS Act, on Tuesday in the local time. The purpose of this is to promote the growth of the industry. This indicates a historic lobbying success for digital asset companies during the Senate's first-ever vote on comprehensive regulatory reforms for cryptocurrencies. The U.S. Senate approved the bill with a vote of 68 in favor and 30 against. Among them, 18 Democrats joined the majority of Republicans to support its advancement to the House of Representatives for review. Led by Republican Senator Bill Hagerty from Tennessee, the bill will for the first time establish a U.S. regulatory framework for stablecoins pegged to the value of the U.S. dollar.

On June 18th, based on HTX market data, Bitcoin experienced a rebound and managed to break through $105,000. The 24-hour decline was narrowed down to 3.35%.

BlockBeats has reported that on June 18th, the US stock Eyenovia saw a surging increase of over 153.56%, and its market capitalization rose to $21.36 million. Previously, Eyenovia announced the launch of its HYPE Treasury Reserve Strategy, with the intention of investing $50 million.

On June 18th, according to market sources, the previously banned GMGN platform and some crypto KOLs' X accounts have now been unblocked. As was previously reported by BlockBeats, on June 12th, the X platform suddenly carried out a large-scale account suspension targeting Crypto users. Accounts such as Eliza, the official GMGN Twitter account, and several MEME KOL accounts were banned. This included @Wolfy_XBT (Kill the Wolf), @brc20niubi (Wang Xiaoer), @0xCryptoWizard (Wizard), @Ga__ke (Gake), the official GMGN account @gmgnai, and the GMGN founder's account @haze0x. The specific reason for these suspensions remains unknown.

On June 18th, based on HTX market data, Ethereum witnessed a rebound and broke through $2500. The 24-hour decline narrowed to 5.59%.

On June 18th, as per market information, the clinical-stage ophthalmic biopharmaceutical company Eyenovia announced a $50 million investment to initiate the Hyperliquid (HYPE) treasury reserve strategy.